TRMT10A
Basic information
Region (hg38): 4:99546709-99564039
Previous symbols: [ "RG9MTD2" ]
Links
Phenotypes
GenCC
Source:
- microcephaly, short stature, and impaired glucose metabolism 1 (Strong), mode of inheritance: AR
- microcephaly, short stature, and impaired glucose metabolism 1 (Strong), mode of inheritance: AR
- primary microcephaly-mild intellectual disability-young-onset diabetes syndrome (Supportive), mode of inheritance: AR
- microcephaly, short stature, and impaired glucose metabolism 1 (Moderate), mode of inheritance: AR
- microcephaly, short stature, and impaired glucose metabolism 1 (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Microcephaly, short stature, and impaired glucose metabolism 1 | AR | Endocrine | Awareness of the risk of diabetes mellitus may allow prompt recognition and treatment | Craniofacial; Endocrine; Musculoskeletal; Neurologic | 24204302; 25053765 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (106 variants)
- Inborn_genetic_diseases (39 variants)
- Microcephaly,_short_stature,_and_impaired_glucose_metabolism_1 (15 variants)
- not_specified (11 variants)
- TRMT10A-related_disorder (4 variants)
- Abnormality_of_the_nervous_system (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRMT10A gene is commonly pathogenic or not. These statistics are base on transcript: NM_001134665.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 24 | 24 | ||||
missense | 67 | 76 | ||||
nonsense | 13 | |||||
start loss | 0 | |||||
frameshift | 6 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
Total | 8 | 11 | 71 | 32 | 0 |
Highest pathogenic variant AF is 0.000311757
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TRMT10A | protein_coding | protein_coding | ENST00000273962 | 7 | 17324 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.89e-10 | 0.331 | 125649 | 0 | 92 | 125741 | 0.000366 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.436 | 166 | 183 | 0.909 | 0.00000978 | 2254 |
Missense in Polyphen | 55 | 57.955 | 0.94901 | 661 | ||
Synonymous | 1.24 | 49 | 61.4 | 0.798 | 0.00000314 | 585 |
Loss of Function | 0.905 | 17 | 21.5 | 0.789 | 0.00000149 | 219 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000326 | 0.000326 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000442 | 0.000435 |
Finnish | 0.00123 | 0.00120 |
European (Non-Finnish) | 0.000372 | 0.000369 |
Middle Eastern | 0.000442 | 0.000435 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: S-adenosyl-L-methionine-dependent guanine N(1)- methyltransferase that catalyzes the formation of N(1)- methylguanine at position 9 (m1G9) in tRNAs (PubMed:23042678, PubMed:25053765). Probably not able to catalyze formation of N(1)- methyladenine at position 9 (m1A9) in tRNAs (PubMed:23042678). {ECO:0000269|PubMed:23042678, ECO:0000269|PubMed:25053765}.;
- Pathway
- tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
(Consensus)
Recessive Scores
- pRec
- 0.0909
Intolerance Scores
- loftool
- rvis_EVS
- 0.33
- rvis_percentile_EVS
- 73.27
Haploinsufficiency Scores
- pHI
- 0.143
- hipred
- N
- hipred_score
- 0.169
- ghis
- 0.515
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Trmt10a
- Phenotype
- growth/size/body region phenotype; skeleton phenotype; homeostasis/metabolism phenotype; vision/eye phenotype;
Gene ontology
- Biological process
- tRNA methylation
- Cellular component
- nucleus;nucleoplasm;nucleolus;cytosol;actin cytoskeleton;extracellular exosome
- Molecular function
- tRNA binding;RNA binding;tRNA (guanine-N1-)-methyltransferase activity;tRNA (guanine(9)-N(1))-methyltransferase activity